Timothy L. Denning

Timothy L. Denning

Auto-generated profile, based on publicly available information

Timothy L. Denning

Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2007 in Nature Immunology
Verified
Journal Article
Closed access
TDTimothy L Denning
Timothy L Denning
YWYi-Chong Wang
Yi-Chong Wang
SPSeema R Patel
Seema R Patel
IWIfor R Williams
Ifor R Williams
BPBali Pulendran
Bali Pulendran

23 March 2006 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SDStephanie Dillon
Stephanie Dillon
SASudhanshu Agrawal
Sudhanshu Agrawal
KBKaustuv Banerjee
Kaustuv Banerjee
JLJohn Letterio
John Letterio
TDTimothy L. Denning
Timothy L. Denning
BPBali Pulendran
Bali Pulendran
Emerging evidence suggests critical roles for APCs in suppressing immune responses. Here, we show that zymosan, a stimulus for TLR2 and dectin-1, regulates cytokine secretion in DCs and macrophages to induce immunological tolerance. First, zymosan induces DCs to secrete abundant IL-10 but little IL-6 and IL-12(p70). Induction of IL-10 is dependent on TLR2- and dectin-1–mediated activation of ERK MAPK via a mechanism independent of the activation protein 1 (AP-1) transcription factor c-Fos. Such DCs stimulate antigen-specific CD4+ T cells poorly due to IL-10 and the lack of IL-6. Second, zymosan induces F4-80+ macrophages in the splenic red pulp to secrete TGF-β. Consistent with these effects on APCs, injection of zymosan plus OVA into mice results in OVA-specific T cells that secrete little or no Th1 or Th2 cytokines, but secrete robust levels of IL-10, and are unresponsive to challenge with OVA plus adjuvant. Finally, coinjection of zymosan with OVA plus LPS suppresses the response to OVA via a mechanism dependent on IL-10, TGF-β, and lack of IL-6. Together, our data demonstrate that zymosan stimulates IL-10+IL-12(p70)–IL-6low regulatory DCs and TGF-β+ macrophages to induce immunological tolerance. These data suggest several targets for pharmacological modulation of immune responses in various clinical settings.

28 April 2013 in Nature
Verified
Journal Article
Open access
PDF file
ACAnna Cebula
Anna Cebula
MSMichal Seweryn
Michal Seweryn
GRGrzegorz A. Rempala
Grzegorz A. Rempala
SPSimarjot Singh Pabla
Simarjot Singh Pabla
RMRichard McIndoe
Richard McIndoe
LILeszek Ignatowicz
Leszek Ignatowicz
By using high-throughput sequencing of T-cell receptors, this study shows that thymus-derived regulatory T (Treg) cells constitute most Treg cells in all lymphoid and intestinal organs, including the colon, suggesting that thymic Treg cells and not induced Treg cells dominantly control tolerance to the gut’s antigens such as commensal microbiota. The identity of the intestinal regulatory T (Treg) cells that control autoimmune diseases such as colitis and immune responses to commensal microbes remains ill defined. In this study Anna Cebula et al. use high-throughput sequencing of T-cell receptors to show that the predominant Treg cells in all lymphoid and intestinal organs, including the colon, are derived from the thymus. This challenges the view that induced rather than thymic Treg cells are mainly responsible for the control of intestinal inflammation, although it does not exclude the possibility that induced Treg cells contribute to intestinal homeostasis. Peripheral mechanisms preventing autoimmunity and maintaining tolerance to commensal microbiota involve CD4+Foxp3+ regulatory T (Treg) cells1,2 generated in the thymus or extrathymically by induction of naive CD4+Foxp3− T cells. Previous studies suggested that the T-cell receptor repertoires of thymic Treg cells and induced Treg cells are biased towards self and non-self antigens, respectively3,4,5,6, but their relative contribution in controlling immunopathology, such as colitis and other untoward inflammatory responses triggered by different types of antigens, remains unresolved7. The intestine, and especially the colon, is a particularly suitable organ to study this question, given the variety of self-, microbiota- and food-derived antigens to which Treg cells and other T-cell populations are exposed. Intestinal environments can enhance conversion to a regulatory lineage8,9 and favour tolerogenic presentation of antigens to naive CD4+ T cells10,11, suggesting that intestinal homeostasis depends on microbiota-specific induced Treg cells12,13,14,15. Here, to identify the origin and antigen-specificity of intestinal Treg cells, we performed single-cell and high-throughput sequencing of the T-cell receptor repertoires of CD4+Foxp3+ and CD4+Foxp3− T cells, and analysed their reactivity against specific commensal species. We show that thymus-derived Treg cells constitute most Treg cells in all lymphoid and intestinal organs, including the colon, where their repertoire is heavily influenced by the composition of the microbiota. Our results suggest that thymic Treg cells, and not induced Treg cells, dominantly mediate tolerance to antigens produced by intestinal commensals.

15 July 2011 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TDTimothy L. Denning
Timothy L. Denning
BNBrian A Norris
Brian A Norris
Oscar Medina-ContrerasOscar Medina-Contreras
Oscar Medina-Contreras
SMSanthakumar Manicassamy
Santhakumar Manicassamy
DGDuke Geem
Duke Geem
BPBali Pulendran
Bali Pulendran
Although several subsets of intestinal APCs have been described, there has been no systematic evaluation of their phenotypes, functions, and regional localization to date. In this article, we used 10-color flow cytometry to define the major APC subsets in the small and large intestine lamina propria. Lamina propria APCs could be subdivided into CD11c+CD11b−, CD11c+CD11b+, and CD11cdullCD11b+ subsets. CD11c+CD11b− cells were largely CD103+F4/80− dendritic cells (DCs), whereas the CD11c+CD11b+ subset comprised CD11c+CD11b+CD103+F4/80− DCs and CD11c+CD11b+CD103−F4/80+ macrophage-like cells. The majority of CD11cdullCD11b+ cells were CD103−F4/80+ macrophages. Although macrophages were more efficient at inducing Foxp3+ regulatory T (Treg) cells than DCs, at higher T cell/APC ratios, all of the DC subsets efficiently induced Foxp3+ Treg cells. In contrast, only CD11c+CD11b+CD103+ DCs efficiently induced Th17 cells. Consistent with this, the regional distribution of CD11c+CD11b+CD103+ DCs correlated with that of Th17 cells, with duodenum > jejunum > ileum > colon. Conversely, CD11c+CD11b−CD103+ DCs, macrophages, and Foxp3+ Treg cells were most abundant in the colon and scarce in the duodenum. Importantly, however, the ability of DC and macrophage subsets to induce Foxp3+ Treg cells versus Th17 cells was strikingly dependent on the source of the mouse strain. Thus, DCs from C57BL/6 mice from Charles River Laboratories (that have segmented filamentous bacteria, which induce robust levels of Th17 cells in situ) were more efficient at inducing Th17 cells and less efficient at inducing Foxp3+ Treg cells than DCs from B6 mice from The Jackson Laboratory. Thus, the functional specializations of APC subsets in the intestine are dependent on the T cell/APC ratio, regional localization, and source of the mouse strain.

1 December 2011 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Oscar Medina-ContrerasOscar Medina-Contreras
Oscar Medina-Contreras
DGDuke Geem
Duke Geem
OLOskar Laur
Oskar Laur
IWIfor R. Williams
Ifor R. Williams
SLSergio A. Lira
Sergio A. Lira
TDTimothy L. Denning
Timothy L. Denning
The two most common forms of inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, affect approximately 1 million people in the United States. Uncontrolled APC reactivity toward commensal bacteria is implicated in the pathogenesis of the disease. A number of functionally distinct APC populations exist in the mucosal lamina propria (LP) below the intestinal epithelium, but their relative contributions to inflammation remain unclear. Here, we demonstrate in mice important roles for the chemokine receptor CX3CR1 in maintaining LP macrophage populations, preventing translocation of commensal bacteria to mesenteric lymph nodes (mLNs), and limiting colitogenic Th17 responses. CX3CR1 was found to be expressed in resident LP macrophages (defined as CD11b+F4/80+) but not DCs (defined as CD11c+CD103+). LP macrophage frequency and number were decreased in two strains of CX3CR1-knockout mice and in mice deficient in the CX3CR1 ligand CX3CL1. All these knockout strains displayed markedly increased translocation of commensal bacteria to mLNs. Additionally, the severity of DSS-induced colitis was dramatically enhanced in the knockout mice as compared with controls. Disease severity could be limited by either administration of neutralizing IL-17A antibodies or transfer of CX3CR1-sufficient macrophages. Our data thus suggest key roles for the CX3CR1/CX3CL1 axis in the intestinal mucosa; further clarification of CX3CR1 function will likely direct efforts toward therapeutic intervention for mucosal inflammatory disorders such as IBD.

15 July 2015 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
GLG Leoni
G Leoni
PNP-A Neumann
P-A Neumann
RSR Sumagin
R Sumagin
TDT L Denning
T L Denning
ANA Nusrat
A Nusrat
The epithelium serves as a highly selective barrier at mucosal surfaces. Upon injury, epithelial wound closure is orchestrated by a series of events that emanate from the epithelium itself as well as by the temporal recruitment of immune cells into the wound bed. Epithelial cells adjoining the wound flatten out, migrate, and proliferate to rapidly cover denuded surfaces and re-establish mucosal homeostasis. This process is highly regulated by proteins and lipids, proresolving mediators such as Annexin A1 protein and resolvins released into the epithelial milieu by the epithelium itself and infiltrating innate immune cells including neutrophils and macrophages. Failure to achieve these finely tuned processes is observed in chronic inflammatory diseases that are associated with non-healing wounds. An improved understanding of mechanisms that mediate repair is important in the development of therapeutics aimed to promote mucosal wound repair.